 Kristi Anseth
Concepts (678)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogels | 155 | 2023 | 581 | 27.050 |
Why?
| | Polyethylene Glycols | 116 | 2023 | 576 | 18.220 |
Why?
| | Biocompatible Materials | 81 | 2023 | 378 | 12.490 |
Why?
| | Extracellular Matrix | 55 | 2023 | 439 | 9.520 |
Why?
| | Tissue Engineering | 55 | 2023 | 366 | 8.360 |
Why?
| | Cell Culture Techniques | 34 | 2023 | 344 | 6.750 |
Why?
| | Myofibroblasts | 16 | 2023 | 116 | 5.650 |
Why?
| | Chondrocytes | 24 | 2021 | 199 | 5.410 |
Why?
| | Aortic Valve | 23 | 2022 | 397 | 5.300 |
Why?
| | Heart Valves | 14 | 2019 | 41 | 4.900 |
Why?
| | Polymers | 45 | 2022 | 463 | 4.870 |
Why?
| | Sulfhydryl Compounds | 18 | 2020 | 178 | 4.430 |
Why?
| | Calcinosis | 11 | 2022 | 242 | 4.360 |
Why?
| | Cells, Cultured | 78 | 2023 | 3914 | 4.250 |
Why?
| | Organoids | 8 | 2023 | 74 | 4.050 |
Why?
| | Mechanotransduction, Cellular | 9 | 2023 | 97 | 3.800 |
Why?
| | Cross-Linking Reagents | 32 | 2018 | 182 | 3.660 |
Why?
| | Fibroblasts | 18 | 2023 | 839 | 3.590 |
Why?
| | Cell Differentiation | 33 | 2022 | 1700 | 3.500 |
Why?
| | Osteogenesis | 15 | 2020 | 184 | 3.440 |
Why?
| | Elasticity | 17 | 2020 | 195 | 3.270 |
Why?
| | Tissue Scaffolds | 17 | 2022 | 180 | 3.260 |
Why?
| | Oligopeptides | 18 | 2013 | 248 | 3.210 |
Why?
| | Aortic Valve Stenosis | 8 | 2022 | 272 | 3.210 |
Why?
| | Swine | 35 | 2022 | 706 | 2.990 |
Why?
| | Click Chemistry | 10 | 2021 | 50 | 2.940 |
Why?
| | Cell Survival | 36 | 2023 | 1024 | 2.890 |
Why?
| | Photochemistry | 32 | 2021 | 125 | 2.880 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 17 | 2016 | 74 | 2.850 |
Why?
| | Osteoblasts | 13 | 2022 | 106 | 2.800 |
Why?
| | Biomimetic Materials | 11 | 2018 | 64 | 2.710 |
Why?
| | Animals | 132 | 2023 | 32104 | 2.550 |
Why?
| | Light | 22 | 2020 | 337 | 2.450 |
Why?
| | Cellular Microenvironment | 7 | 2022 | 78 | 2.440 |
Why?
| | Hydrazones | 6 | 2022 | 21 | 2.340 |
Why?
| | Peptides | 15 | 2015 | 864 | 2.280 |
Why?
| | Drug Delivery Systems | 14 | 2019 | 301 | 2.220 |
Why?
| | Photolysis | 9 | 2020 | 79 | 2.200 |
Why?
| | Materials Testing | 34 | 2019 | 356 | 2.140 |
Why?
| | Cartilage | 12 | 2018 | 182 | 2.010 |
Why?
| | Transforming Growth Factor beta1 | 12 | 2020 | 156 | 1.930 |
Why?
| | Cell Communication | 10 | 2016 | 282 | 1.930 |
Why?
| | Cell Adhesion | 21 | 2014 | 433 | 1.880 |
Why?
| | Cell Movement | 9 | 2015 | 867 | 1.880 |
Why?
| | Proteins | 7 | 2023 | 920 | 1.840 |
Why?
| | Matrix Metalloproteinases | 9 | 2017 | 88 | 1.780 |
Why?
| | Photochemical Processes | 12 | 2018 | 97 | 1.780 |
Why?
| | Cartilage, Articular | 8 | 2021 | 291 | 1.740 |
Why?
| | Collagen | 14 | 2021 | 416 | 1.680 |
Why?
| | Actins | 16 | 2022 | 383 | 1.660 |
Why?
| | Insulin-Secreting Cells | 7 | 2014 | 318 | 1.640 |
Why?
| | Intestines | 4 | 2023 | 324 | 1.630 |
Why?
| | Microscopy | 2 | 2023 | 125 | 1.540 |
Why?
| | Esters | 4 | 2020 | 61 | 1.510 |
Why?
| | Melanoma | 4 | 2021 | 651 | 1.460 |
Why?
| | Azides | 5 | 2022 | 47 | 1.420 |
Why?
| | Paracrine Communication | 3 | 2020 | 56 | 1.330 |
Why?
| | Cells, Immobilized | 7 | 2018 | 21 | 1.290 |
Why?
| | Cadherins | 3 | 2022 | 175 | 1.260 |
Why?
| | Mice | 46 | 2023 | 15052 | 1.260 |
Why?
| | Islets of Langerhans | 7 | 2010 | 729 | 1.260 |
Why?
| | Signal Transduction | 15 | 2022 | 4541 | 1.240 |
Why?
| | Myoblasts | 5 | 2023 | 74 | 1.230 |
Why?
| | Fibrosis | 7 | 2022 | 457 | 1.230 |
Why?
| | Molecular Structure | 19 | 2018 | 447 | 1.190 |
Why?
| | Extracellular Matrix Proteins | 4 | 2013 | 127 | 1.190 |
Why?
| | Coated Materials, Biocompatible | 5 | 2011 | 57 | 1.190 |
Why?
| | Anhydrides | 8 | 2010 | 18 | 1.180 |
Why?
| | Polymerization | 7 | 2018 | 119 | 1.180 |
Why?
| | Fibroblast Growth Factor 2 | 5 | 2008 | 83 | 1.170 |
Why?
| | Indoles | 4 | 2017 | 309 | 1.160 |
Why?
| | Spheroids, Cellular | 3 | 2017 | 57 | 1.130 |
Why?
| | Humans | 102 | 2023 | 115739 | 1.130 |
Why?
| | Cell Proliferation | 20 | 2022 | 2194 | 1.120 |
Why?
| | Elastic Modulus | 8 | 2017 | 118 | 1.120 |
Why?
| | Serum | 3 | 2022 | 57 | 1.120 |
Why?
| | Adaptor Proteins, Signal Transducing | 6 | 2021 | 374 | 1.110 |
Why?
| | Capsules | 7 | 2019 | 36 | 1.110 |
Why?
| | Phenotype | 11 | 2023 | 2839 | 1.080 |
Why?
| | Gels | 8 | 2008 | 72 | 1.070 |
Why?
| | Gene Expression | 9 | 2022 | 1436 | 1.060 |
Why?
| | Sulfides | 4 | 2022 | 94 | 1.050 |
Why?
| | Islets of Langerhans Transplantation | 4 | 2010 | 63 | 1.040 |
Why?
| | Allyl Compounds | 3 | 2022 | 15 | 1.030 |
Why?
| | Acrylates | 11 | 2012 | 47 | 1.020 |
Why?
| | Transforming Growth Factor beta | 5 | 2014 | 446 | 1.010 |
Why?
| | Sus scrofa | 6 | 2020 | 45 | 1.010 |
Why?
| | Heparin | 6 | 2010 | 227 | 0.990 |
Why?
| | Cell Line | 14 | 2023 | 2651 | 0.960 |
Why?
| | Mechanical Phenomena | 3 | 2019 | 83 | 0.960 |
Why?
| | Staphylococcus epidermidis | 3 | 2010 | 71 | 0.950 |
Why?
| | Vancomycin | 3 | 2010 | 76 | 0.920 |
Why?
| | Bone Regeneration | 4 | 2020 | 21 | 0.910 |
Why?
| | Viscosity | 4 | 2020 | 83 | 0.910 |
Why?
| | Collagenases | 3 | 2015 | 22 | 0.910 |
Why?
| | Acrylic Resins | 2 | 2021 | 38 | 0.910 |
Why?
| | Heart Valve Diseases | 3 | 2014 | 159 | 0.910 |
Why?
| | Kinetics | 20 | 2020 | 1569 | 0.900 |
Why?
| | Regenerative Medicine | 2 | 2017 | 41 | 0.900 |
Why?
| | Polyesters | 6 | 2009 | 65 | 0.880 |
Why?
| | Norbornanes | 3 | 2013 | 13 | 0.870 |
Why?
| | Delayed-Action Preparations | 10 | 2018 | 159 | 0.870 |
Why?
| | Bone Substitutes | 5 | 2019 | 29 | 0.870 |
Why?
| | Sulfonamides | 3 | 2017 | 447 | 0.860 |
Why?
| | Rats | 26 | 2022 | 5033 | 0.820 |
Why?
| | Alkynes | 5 | 2022 | 54 | 0.820 |
Why?
| | Peptide Fragments | 4 | 2013 | 675 | 0.810 |
Why?
| | Genes, X-Linked | 1 | 2022 | 17 | 0.800 |
Why?
| | Podosomes | 1 | 2021 | 3 | 0.800 |
Why?
| | X Chromosome Inactivation | 1 | 2022 | 21 | 0.800 |
Why?
| | Osteoporosis, Postmenopausal | 1 | 2022 | 36 | 0.800 |
Why?
| | Stress, Mechanical | 9 | 2021 | 462 | 0.770 |
Why?
| | Skull | 5 | 2012 | 117 | 0.770 |
Why?
| | Elastomers | 1 | 2021 | 29 | 0.760 |
Why?
| | Intestinal Mucosa | 5 | 2023 | 528 | 0.760 |
Why?
| | NIH 3T3 Cells | 11 | 2020 | 137 | 0.760 |
Why?
| | Dexamethasone | 4 | 2013 | 316 | 0.760 |
Why?
| | Cattle | 18 | 2018 | 935 | 0.760 |
Why?
| | Chondrogenesis | 4 | 2011 | 79 | 0.750 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2021 | 1137 | 0.750 |
Why?
| | Myocytes, Cardiac | 5 | 2020 | 457 | 0.740 |
Why?
| | Calcium Signaling | 2 | 2020 | 211 | 0.730 |
Why?
| | Bone and Bones | 5 | 2019 | 283 | 0.730 |
Why?
| | Mechanoreceptors | 1 | 2020 | 12 | 0.730 |
Why?
| | Inflammation Mediators | 2 | 2020 | 479 | 0.720 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2021 | 91 | 0.710 |
Why?
| | Tumor Microenvironment | 3 | 2021 | 431 | 0.700 |
Why?
| | Regeneration | 4 | 2016 | 162 | 0.700 |
Why?
| | Rheology | 6 | 2020 | 88 | 0.690 |
Why?
| | Fluorescent Dyes | 5 | 2015 | 304 | 0.690 |
Why?
| | Drug Carriers | 7 | 2017 | 113 | 0.690 |
Why?
| | Phosphates | 3 | 2012 | 160 | 0.680 |
Why?
| | Models, Biological | 8 | 2015 | 1646 | 0.670 |
Why?
| | Anthracenes | 1 | 2019 | 28 | 0.670 |
Why?
| | Methacrylates | 6 | 2012 | 110 | 0.660 |
Why?
| | Osteoporosis | 1 | 2022 | 227 | 0.650 |
Why?
| | Proteoglycans | 3 | 2013 | 107 | 0.650 |
Why?
| | Azo Compounds | 2 | 2018 | 25 | 0.650 |
Why?
| | Biophysics | 1 | 2019 | 70 | 0.640 |
Why?
| | Transcriptome | 5 | 2022 | 736 | 0.640 |
Why?
| | Aza Compounds | 1 | 2018 | 11 | 0.640 |
Why?
| | Cyclooctanes | 1 | 2018 | 5 | 0.640 |
Why?
| | Viscoelastic Substances | 2 | 2020 | 9 | 0.640 |
Why?
| | Models, Chemical | 7 | 2009 | 257 | 0.630 |
Why?
| | Lactic Acid | 6 | 2016 | 275 | 0.630 |
Why?
| | Surface Properties | 12 | 2012 | 397 | 0.620 |
Why?
| | Precision Medicine | 2 | 2022 | 344 | 0.620 |
Why?
| | Peptides, Cyclic | 2 | 2010 | 262 | 0.620 |
Why?
| | Pulmonary Alveoli | 3 | 2017 | 376 | 0.610 |
Why?
| | Proto-Oncogene Proteins B-raf | 2 | 2021 | 192 | 0.610 |
Why?
| | Fibronectins | 6 | 2012 | 108 | 0.600 |
Why?
| | Alkaline Phosphatase | 8 | 2016 | 144 | 0.600 |
Why?
| | Hyaluronic Acid | 5 | 2018 | 190 | 0.600 |
Why?
| | Insulin | 9 | 2014 | 2082 | 0.600 |
Why?
| | Nanoparticles | 3 | 2018 | 315 | 0.590 |
Why?
| | Molecular Probes | 1 | 2017 | 30 | 0.590 |
Why?
| | Cell Line, Tumor | 10 | 2017 | 2751 | 0.580 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 152 | 0.570 |
Why?
| | Antigens | 3 | 2013 | 323 | 0.560 |
Why?
| | Biopolymers | 3 | 2022 | 26 | 0.560 |
Why?
| | DNA | 6 | 2006 | 1356 | 0.550 |
Why?
| | Apoptosis | 10 | 2017 | 2377 | 0.550 |
Why?
| | Macromolecular Substances | 3 | 2017 | 200 | 0.540 |
Why?
| | Lipase | 2 | 2007 | 66 | 0.540 |
Why?
| | Cell Self Renewal | 1 | 2016 | 49 | 0.530 |
Why?
| | Myocardium | 4 | 2023 | 926 | 0.530 |
Why?
| | Coculture Techniques | 6 | 2019 | 202 | 0.530 |
Why?
| | Gene Expression Regulation | 8 | 2022 | 2353 | 0.530 |
Why?
| | Amino Acid Sequence | 7 | 2015 | 2000 | 0.530 |
Why?
| | Microspheres | 2 | 2015 | 122 | 0.520 |
Why?
| | Muscle, Smooth | 4 | 2009 | 150 | 0.510 |
Why?
| | Microarray Analysis | 1 | 2015 | 119 | 0.510 |
Why?
| | Macrophages | 2 | 2020 | 1284 | 0.500 |
Why?
| | Bone Morphogenetic Protein 2 | 2 | 2012 | 75 | 0.490 |
Why?
| | Rats, Sprague-Dawley | 11 | 2022 | 2262 | 0.490 |
Why?
| | Niacinamide | 1 | 2015 | 65 | 0.490 |
Why?
| | Phenylurea Compounds | 1 | 2015 | 83 | 0.480 |
Why?
| | Solubility | 5 | 2020 | 226 | 0.470 |
Why?
| | Staphylococcal Infections | 2 | 2009 | 337 | 0.470 |
Why?
| | 3T3 Cells | 4 | 2012 | 137 | 0.470 |
Why?
| | Immobilized Proteins | 1 | 2014 | 12 | 0.460 |
Why?
| | Protein Kinase Inhibitors | 2 | 2021 | 790 | 0.460 |
Why?
| | Immunohistochemistry | 7 | 2022 | 1642 | 0.460 |
Why?
| | Microscopy, Confocal | 4 | 2012 | 299 | 0.460 |
Why?
| | Factor XIIIa | 1 | 2013 | 5 | 0.460 |
Why?
| | Cell Engineering | 1 | 2013 | 7 | 0.450 |
Why?
| | Antibodies | 2 | 2006 | 374 | 0.450 |
Why?
| | Mammals | 3 | 2023 | 251 | 0.450 |
Why?
| | Epithelial Cells | 4 | 2022 | 961 | 0.450 |
Why?
| | Biomarkers | 5 | 2022 | 3471 | 0.450 |
Why?
| | Biochemistry | 1 | 2014 | 40 | 0.450 |
Why?
| | Prostheses and Implants | 5 | 2009 | 140 | 0.440 |
Why?
| | Serum Albumin, Bovine | 2 | 2018 | 65 | 0.440 |
Why?
| | Microfluidics | 3 | 2010 | 50 | 0.440 |
Why?
| | beta Catenin | 1 | 2015 | 220 | 0.430 |
Why?
| | Orthopedics | 4 | 2007 | 125 | 0.430 |
Why?
| | Compressive Strength | 5 | 2021 | 73 | 0.430 |
Why?
| | Cytokines | 1 | 2020 | 1853 | 0.420 |
Why?
| | Stem Cells | 3 | 2022 | 546 | 0.420 |
Why?
| | Nanocapsules | 1 | 2012 | 8 | 0.420 |
Why?
| | Polystyrenes | 5 | 2014 | 36 | 0.420 |
Why?
| | Time Factors | 14 | 2011 | 6171 | 0.420 |
Why?
| | Disease Progression | 3 | 2021 | 2423 | 0.410 |
Why?
| | Leukocyte Elastase | 2 | 2009 | 79 | 0.410 |
Why?
| | Microfluidic Analytical Techniques | 4 | 2018 | 72 | 0.410 |
Why?
| | Molecular Weight | 5 | 2014 | 329 | 0.400 |
Why?
| | Biomechanical Phenomena | 6 | 2017 | 680 | 0.400 |
Why?
| | Nerve Net | 1 | 2014 | 228 | 0.390 |
Why?
| | Embryonic Stem Cells | 2 | 2014 | 105 | 0.390 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2013 | 314 | 0.380 |
Why?
| | Printing, Three-Dimensional | 2 | 2022 | 63 | 0.380 |
Why?
| | Awards and Prizes | 1 | 2012 | 56 | 0.380 |
Why?
| | MAP Kinase Signaling System | 3 | 2021 | 275 | 0.380 |
Why?
| | Endothelial Cells | 2 | 2014 | 696 | 0.380 |
Why?
| | TRPV Cation Channels | 2 | 2022 | 28 | 0.380 |
Why?
| | Culture Media | 4 | 2014 | 156 | 0.380 |
Why?
| | Gelatin | 2 | 2017 | 36 | 0.370 |
Why?
| | Metalloporphyrins | 1 | 2011 | 106 | 0.370 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 7 | 2012 | 930 | 0.370 |
Why?
| | Titanium | 2 | 2010 | 74 | 0.360 |
Why?
| | Superoxides | 1 | 2011 | 215 | 0.360 |
Why?
| | Anti-Bacterial Agents | 2 | 2010 | 1485 | 0.360 |
Why?
| | Collagen Type I | 4 | 2020 | 110 | 0.360 |
Why?
| | Organ Culture Techniques | 1 | 2010 | 143 | 0.360 |
Why?
| | Prosthesis-Related Infections | 2 | 2009 | 70 | 0.360 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2010 | 17 | 0.350 |
Why?
| | Heart Defects, Congenital | 2 | 2014 | 666 | 0.350 |
Why?
| | Fibrosarcoma | 1 | 2009 | 20 | 0.350 |
Why?
| | Phosphinic Acids | 1 | 2009 | 9 | 0.340 |
Why?
| | Cardiomyopathies | 1 | 2013 | 303 | 0.340 |
Why?
| | fas Receptor | 1 | 2010 | 93 | 0.340 |
Why?
| | Phosphoproteins | 3 | 2017 | 304 | 0.340 |
Why?
| | Transcription Factors | 4 | 2021 | 1528 | 0.340 |
Why?
| | Magnetic Resonance Spectroscopy | 7 | 2009 | 483 | 0.340 |
Why?
| | Pravastatin | 1 | 2009 | 28 | 0.340 |
Why?
| | Equipment Design | 4 | 2017 | 517 | 0.340 |
Why?
| | Parathyroid Hormone | 2 | 2020 | 95 | 0.340 |
Why?
| | Chemokine CCL2 | 1 | 2009 | 105 | 0.340 |
Why?
| | Recombinant Proteins | 5 | 2012 | 1243 | 0.340 |
Why?
| | Polyvinyl Alcohol | 4 | 2002 | 14 | 0.340 |
Why?
| | Plasmids | 4 | 2007 | 345 | 0.330 |
Why?
| | Superoxide Dismutase | 1 | 2011 | 332 | 0.330 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2009 | 37 | 0.330 |
Why?
| | Bioprinting | 2 | 2022 | 19 | 0.330 |
Why?
| | Molecular Sequence Data | 4 | 2015 | 2790 | 0.330 |
Why?
| | Enzymes | 1 | 2009 | 61 | 0.320 |
Why?
| | Cycloaddition Reaction | 5 | 2021 | 24 | 0.320 |
Why?
| | Heart Valve Prosthesis | 3 | 2005 | 122 | 0.320 |
Why?
| | Dendritic Cells | 1 | 2012 | 438 | 0.320 |
Why?
| | Trans-Activators | 3 | 2021 | 370 | 0.320 |
Why?
| | T-Lymphocytes | 3 | 2012 | 1756 | 0.320 |
Why?
| | Protein Binding | 6 | 2010 | 1917 | 0.320 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2009 | 101 | 0.310 |
Why?
| | Hemodynamics | 1 | 2013 | 1024 | 0.310 |
Why?
| | Protein Engineering | 2 | 2008 | 104 | 0.310 |
Why?
| | In Vitro Techniques | 5 | 2014 | 1044 | 0.310 |
Why?
| | Polyhydroxyethyl Methacrylate | 3 | 2007 | 10 | 0.310 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 445 | 0.310 |
Why?
| | Biofilms | 1 | 2010 | 222 | 0.310 |
Why?
| | Transfection | 5 | 2011 | 866 | 0.310 |
Why?
| | Smad Proteins | 1 | 2008 | 37 | 0.300 |
Why?
| | Glucose Oxidase | 4 | 2011 | 18 | 0.300 |
Why?
| | Microscopy, Electron, Scanning | 7 | 2012 | 194 | 0.300 |
Why?
| | Glucocorticoids | 1 | 2012 | 552 | 0.300 |
Why?
| | Bone Cements | 2 | 2010 | 37 | 0.300 |
Why?
| | Glucose | 6 | 2014 | 904 | 0.290 |
Why?
| | Ultraviolet Rays | 5 | 2009 | 372 | 0.290 |
Why?
| | Students | 1 | 2012 | 503 | 0.290 |
Why?
| | Anoikis | 1 | 2007 | 31 | 0.290 |
Why?
| | Collagen Type II | 4 | 2009 | 48 | 0.280 |
Why?
| | Shear Strength | 2 | 2020 | 65 | 0.280 |
Why?
| | Aorta | 1 | 2009 | 397 | 0.280 |
Why?
| | Growth Substances | 3 | 2003 | 136 | 0.270 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2006 | 47 | 0.270 |
Why?
| | Adsorption | 4 | 2012 | 125 | 0.270 |
Why?
| | Cell Nucleus | 2 | 2020 | 553 | 0.270 |
Why?
| | Cell Shape | 3 | 2022 | 54 | 0.270 |
Why?
| | Nerve Tissue | 1 | 2005 | 7 | 0.260 |
Why?
| | Biology | 2 | 2017 | 78 | 0.260 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 3 | 2014 | 41 | 0.260 |
Why?
| | Extracellular Fluid | 1 | 2005 | 32 | 0.260 |
Why?
| | Porosity | 2 | 2019 | 93 | 0.250 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 373 | 0.250 |
Why?
| | Biodegradation, Environmental | 6 | 2003 | 80 | 0.250 |
Why?
| | Temperature | 4 | 2013 | 587 | 0.250 |
Why?
| | Staining and Labeling | 3 | 2015 | 139 | 0.250 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2005 | 14 | 0.250 |
Why?
| | Cell Separation | 2 | 2018 | 293 | 0.250 |
Why?
| | MicroRNAs | 1 | 2011 | 607 | 0.250 |
Why?
| | Bioprosthesis | 1 | 2005 | 37 | 0.250 |
Why?
| | Microscopy, Atomic Force | 3 | 2017 | 115 | 0.250 |
Why?
| | Ultrasonography | 1 | 2008 | 642 | 0.240 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 4 | 2010 | 795 | 0.240 |
Why?
| | Organophosphates | 1 | 2005 | 90 | 0.240 |
Why?
| | Polyanhydrides | 1 | 2004 | 2 | 0.240 |
Why?
| | Primary Cell Culture | 3 | 2016 | 149 | 0.240 |
Why?
| | Guided Tissue Regeneration | 1 | 2004 | 13 | 0.240 |
Why?
| | Cell Membrane | 3 | 2013 | 683 | 0.240 |
Why?
| | Diffusion | 4 | 2009 | 120 | 0.230 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 4 | 2010 | 76 | 0.230 |
Why?
| | Cell Transplantation | 1 | 2003 | 37 | 0.230 |
Why?
| | Nitrites | 1 | 2004 | 76 | 0.230 |
Why?
| | Reproducibility of Results | 3 | 2020 | 2824 | 0.220 |
Why?
| | Cell Cycle | 2 | 2019 | 546 | 0.220 |
Why?
| | Chemistry, Pharmaceutical | 2 | 2017 | 99 | 0.220 |
Why?
| | Male | 16 | 2022 | 56048 | 0.220 |
Why?
| | Drug Design | 3 | 2012 | 156 | 0.220 |
Why?
| | Aldehydes | 2 | 2014 | 144 | 0.220 |
Why?
| | Microscopy, Fluorescence | 3 | 2012 | 402 | 0.220 |
Why?
| | Neurons | 3 | 2010 | 1298 | 0.210 |
Why?
| | Endoglin | 2 | 2016 | 20 | 0.210 |
Why?
| | Butadienes | 1 | 2003 | 31 | 0.210 |
Why?
| | Weight-Bearing | 1 | 2004 | 165 | 0.210 |
Why?
| | Annexin A2 | 1 | 2022 | 10 | 0.210 |
Why?
| | Calcium | 3 | 2014 | 1103 | 0.210 |
Why?
| | Axons | 2 | 2014 | 179 | 0.210 |
Why?
| | Laminin | 3 | 2008 | 69 | 0.210 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2012 | 1870 | 0.210 |
Why?
| | Mice, Inbred BALB C | 3 | 2010 | 1168 | 0.210 |
Why?
| | Calcification, Physiologic | 1 | 2002 | 35 | 0.210 |
Why?
| | Particle Size | 4 | 2012 | 319 | 0.210 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2022 | 23 | 0.200 |
Why?
| | Muscle Contraction | 2 | 2019 | 397 | 0.200 |
Why?
| | Receptors, Cell Surface | 3 | 2008 | 356 | 0.200 |
Why?
| | Sex Factors | 3 | 2022 | 1739 | 0.200 |
Why?
| | Gene Expression Profiling | 2 | 2022 | 1537 | 0.200 |
Why?
| | Interstitial Cells of Cajal | 2 | 2019 | 4 | 0.200 |
Why?
| | Morphogenesis | 1 | 2023 | 161 | 0.200 |
Why?
| | Robotics | 1 | 2023 | 78 | 0.200 |
Why?
| | Ovariectomy | 1 | 2022 | 117 | 0.200 |
Why?
| | Mice, Nude | 4 | 2015 | 639 | 0.200 |
Why?
| | Osteopontin | 3 | 2006 | 32 | 0.190 |
Why?
| | Organogenesis | 1 | 2022 | 54 | 0.190 |
Why?
| | Membrane Proteins | 2 | 2020 | 1024 | 0.190 |
Why?
| | Isoelectric Point | 1 | 2021 | 22 | 0.190 |
Why?
| | Drug Compounding | 4 | 2005 | 89 | 0.190 |
Why?
| | Base Sequence | 4 | 2012 | 2114 | 0.190 |
Why?
| | Vinculin | 2 | 2013 | 10 | 0.190 |
Why?
| | Temporomandibular Joint | 1 | 2001 | 10 | 0.190 |
Why?
| | Focal Adhesions | 2 | 2015 | 42 | 0.190 |
Why?
| | Glycosaminoglycans | 4 | 2008 | 80 | 0.190 |
Why?
| | Sialoglycoproteins | 3 | 2006 | 158 | 0.190 |
Why?
| | Isoproterenol | 1 | 2021 | 110 | 0.190 |
Why?
| | Secretory Pathway | 1 | 2020 | 5 | 0.180 |
Why?
| | THP-1 Cells | 1 | 2020 | 20 | 0.180 |
Why?
| | Muramidase | 2 | 2012 | 73 | 0.180 |
Why?
| | Tricarboxylic Acids | 1 | 2000 | 10 | 0.180 |
Why?
| | Bacterial Adhesion | 2 | 2012 | 78 | 0.180 |
Why?
| | Wound Healing | 4 | 2022 | 257 | 0.180 |
Why?
| | Chromatography, Gel | 3 | 2007 | 128 | 0.180 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2021 | 133 | 0.180 |
Why?
| | Hydroxamic Acids | 1 | 2020 | 80 | 0.180 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2021 | 169 | 0.180 |
Why?
| | Fluoresceins | 2 | 2012 | 46 | 0.170 |
Why?
| | Acetylation | 1 | 2020 | 212 | 0.170 |
Why?
| | Matrix Metalloproteinase 9 | 2 | 2017 | 117 | 0.170 |
Why?
| | Photosensitizing Agents | 1 | 2000 | 26 | 0.170 |
Why?
| | Hexanes | 1 | 1999 | 3 | 0.170 |
Why?
| | Dicarboxylic Acids | 1 | 1999 | 6 | 0.170 |
Why?
| | Adipogenesis | 2 | 2011 | 42 | 0.170 |
Why?
| | Cardiomegaly | 1 | 2020 | 161 | 0.170 |
Why?
| | DNA Primers | 3 | 2012 | 514 | 0.170 |
Why?
| | Boronic Acids | 1 | 2019 | 33 | 0.170 |
Why?
| | Ligands | 2 | 2014 | 569 | 0.170 |
Why?
| | Triazoles | 1 | 2020 | 132 | 0.170 |
Why?
| | Bone Diseases | 1 | 2019 | 58 | 0.160 |
Why?
| | Antibodies, Immobilized | 1 | 2018 | 1 | 0.160 |
Why?
| | Isomerism | 2 | 2018 | 42 | 0.160 |
Why?
| | Sex Characteristics | 2 | 2022 | 641 | 0.160 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2020 | 199 | 0.160 |
Why?
| | Histone Deacetylases | 1 | 2020 | 196 | 0.160 |
Why?
| | Bioengineering | 1 | 2018 | 13 | 0.160 |
Why?
| | Receptors, Fibroblast Growth Factor | 2 | 2010 | 63 | 0.160 |
Why?
| | Female | 12 | 2022 | 60016 | 0.160 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2013 | 400 | 0.160 |
Why?
| | Phenylacetates | 1 | 2018 | 10 | 0.160 |
Why?
| | Gold | 1 | 2019 | 107 | 0.150 |
Why?
| | Jurkat Cells | 2 | 2010 | 128 | 0.150 |
Why?
| | Metal Nanoparticles | 1 | 2019 | 75 | 0.150 |
Why?
| | Absorbable Implants | 2 | 2009 | 34 | 0.150 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2018 | 59 | 0.150 |
Why?
| | Bacteriophage T4 | 1 | 2018 | 16 | 0.150 |
Why?
| | Equipment Failure Analysis | 2 | 2017 | 135 | 0.150 |
Why?
| | DNA Ligases | 1 | 2018 | 15 | 0.150 |
Why?
| | Chemotaxis | 2 | 2009 | 132 | 0.150 |
Why?
| | beta-Cyclodextrins | 1 | 2018 | 28 | 0.150 |
Why?
| | Animals, Newborn | 3 | 2006 | 780 | 0.150 |
Why?
| | Dendrimers | 1 | 2017 | 13 | 0.150 |
Why?
| | A549 Cells | 1 | 2017 | 51 | 0.150 |
Why?
| | Absorption | 2 | 2009 | 52 | 0.150 |
Why?
| | Heart Diseases | 1 | 2021 | 331 | 0.150 |
Why?
| | Periodicals as Topic | 2 | 2017 | 183 | 0.150 |
Why?
| | Integrins | 2 | 2009 | 79 | 0.150 |
Why?
| | Hydrolysis | 4 | 2007 | 179 | 0.150 |
Why?
| | Heart | 1 | 2021 | 610 | 0.150 |
Why?
| | Substrate Specificity | 2 | 2009 | 357 | 0.150 |
Why?
| | Biomimetics | 1 | 2017 | 36 | 0.140 |
Why?
| | Nanotubes, Carbon | 1 | 2017 | 43 | 0.140 |
Why?
| | Antigens, Neoplasm | 1 | 2018 | 223 | 0.140 |
Why?
| | Biomedical Engineering | 4 | 2001 | 23 | 0.140 |
Why?
| | Enzyme Stability | 2 | 2018 | 73 | 0.140 |
Why?
| | Rubber | 1 | 1996 | 8 | 0.140 |
Why?
| | Culture Media, Serum-Free | 2 | 2007 | 42 | 0.140 |
Why?
| | Cell Division | 4 | 2004 | 759 | 0.140 |
Why?
| | Elastin | 2 | 2008 | 79 | 0.140 |
Why?
| | DNA, Neoplasm | 1 | 2017 | 157 | 0.140 |
Why?
| | Tensile Strength | 4 | 2003 | 103 | 0.130 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2008 | 515 | 0.130 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2017 | 180 | 0.130 |
Why?
| | Epigenesis, Genetic | 1 | 2020 | 526 | 0.130 |
Why?
| | Hot Temperature | 1 | 2018 | 303 | 0.130 |
Why?
| | Maleimides | 2 | 2013 | 24 | 0.130 |
Why?
| | Furans | 2 | 2013 | 22 | 0.130 |
Why?
| | Nanomedicine | 1 | 2016 | 28 | 0.130 |
Why?
| | Viral Proteins | 1 | 2018 | 286 | 0.130 |
Why?
| | Histones | 1 | 2020 | 540 | 0.130 |
Why?
| | Stromal Cells | 1 | 2015 | 97 | 0.130 |
Why?
| | Disease Models, Animal | 2 | 2022 | 3580 | 0.130 |
Why?
| | Composite Resins | 1 | 1996 | 103 | 0.130 |
Why?
| | Structure-Activity Relationship | 2 | 2009 | 511 | 0.130 |
Why?
| | Medicine | 1 | 2017 | 103 | 0.130 |
Why?
| | Models, Theoretical | 4 | 2007 | 520 | 0.120 |
Why?
| | Computational Biology | 2 | 2022 | 537 | 0.120 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 388 | 0.120 |
Why?
| | Ethylene Glycols | 3 | 2000 | 14 | 0.120 |
Why?
| | Electrophoresis, Agar Gel | 2 | 2004 | 25 | 0.120 |
Why?
| | Cell-Matrix Junctions | 1 | 2014 | 2 | 0.120 |
Why?
| | Cytostatic Agents | 1 | 2014 | 6 | 0.120 |
Why?
| | Streptavidin | 1 | 2014 | 16 | 0.120 |
Why?
| | Acyltransferases | 1 | 2014 | 46 | 0.110 |
Why?
| | Glass | 1 | 2014 | 43 | 0.110 |
Why?
| | Integrin beta1 | 1 | 2013 | 17 | 0.110 |
Why?
| | Benzaldehydes | 1 | 2013 | 8 | 0.110 |
Why?
| | Basal Metabolism | 1 | 2014 | 45 | 0.110 |
Why?
| | Molecular Mimicry | 1 | 2013 | 35 | 0.110 |
Why?
| | CD146 Antigen | 1 | 2013 | 38 | 0.110 |
Why?
| | Stage-Specific Embryonic Antigens | 1 | 2013 | 2 | 0.110 |
Why?
| | Cyclization | 2 | 2011 | 24 | 0.110 |
Why?
| | Benzoquinones | 1 | 2014 | 44 | 0.110 |
Why?
| | Biophysical Phenomena | 1 | 2013 | 63 | 0.110 |
Why?
| | Fluorescence Resonance Energy Transfer | 2 | 2019 | 176 | 0.110 |
Why?
| | Coloring Agents | 1 | 2013 | 71 | 0.110 |
Why?
| | Muscle Cells | 1 | 2013 | 41 | 0.110 |
Why?
| | Cryoultramicrotomy | 1 | 2013 | 3 | 0.110 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2013 | 57 | 0.110 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2014 | 185 | 0.110 |
Why?
| | Decanoic Acids | 2 | 2005 | 7 | 0.110 |
Why?
| | Gelatin Sponge, Absorbable | 1 | 2012 | 5 | 0.110 |
Why?
| | Developmental Biology | 1 | 2012 | 18 | 0.110 |
Why?
| | Sulfhydryl Reagents | 1 | 2012 | 11 | 0.110 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 317 | 0.100 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2013 | 123 | 0.100 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2012 | 42 | 0.100 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2017 | 638 | 0.100 |
Why?
| | Ethers | 1 | 2012 | 16 | 0.100 |
Why?
| | Wnt Proteins | 1 | 2013 | 135 | 0.100 |
Why?
| | Connective Tissue Growth Factor | 1 | 2012 | 21 | 0.100 |
Why?
| | Biofouling | 1 | 2012 | 7 | 0.100 |
Why?
| | Systems Biology | 1 | 2012 | 57 | 0.100 |
Why?
| | Fracture Healing | 1 | 2012 | 76 | 0.100 |
Why?
| | Free Radicals | 1 | 2012 | 98 | 0.100 |
Why?
| | Crystallization | 2 | 2009 | 138 | 0.100 |
Why?
| | Bone Transplantation | 1 | 2012 | 99 | 0.100 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2013 | 332 | 0.100 |
Why?
| | China | 1 | 2012 | 163 | 0.100 |
Why?
| | Endoplasmic Reticulum | 1 | 2013 | 235 | 0.100 |
Why?
| | Receptor, EphA5 | 1 | 2011 | 1 | 0.100 |
Why?
| | Ephrin-A5 | 1 | 2011 | 1 | 0.100 |
Why?
| | Thermodynamics | 1 | 2013 | 388 | 0.100 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2011 | 35 | 0.090 |
Why?
| | Homeostasis | 1 | 2014 | 577 | 0.090 |
Why?
| | Half-Life | 1 | 2011 | 145 | 0.090 |
Why?
| | Blotting, Western | 1 | 2013 | 1153 | 0.090 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2012 | 350 | 0.090 |
Why?
| | Biological Availability | 1 | 2011 | 119 | 0.090 |
Why?
| | Surface Plasmon Resonance | 1 | 2011 | 82 | 0.090 |
Why?
| | Flow Cytometry | 2 | 2011 | 1083 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2013 | 1230 | 0.090 |
Why?
| | Heparin Lyase | 1 | 2010 | 4 | 0.090 |
Why?
| | Cell Physiological Phenomena | 1 | 2010 | 23 | 0.090 |
Why?
| | Ascorbic Acid | 1 | 2011 | 112 | 0.090 |
Why?
| | Carbohydrate Sequence | 1 | 2010 | 23 | 0.090 |
Why?
| | Polymethyl Methacrylate | 1 | 2010 | 20 | 0.090 |
Why?
| | Membrane Glycoproteins | 1 | 2012 | 431 | 0.090 |
Why?
| | Copper | 1 | 2011 | 101 | 0.090 |
Why?
| | Mice, Inbred NOD | 1 | 2012 | 560 | 0.090 |
Why?
| | Proto-Oncogene Proteins | 1 | 2013 | 609 | 0.090 |
Why?
| | Interleukin-10 | 1 | 2012 | 299 | 0.090 |
Why?
| | Foreskin | 1 | 2009 | 5 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2021 | 1729 | 0.090 |
Why?
| | Enzyme Assays | 1 | 2009 | 22 | 0.090 |
Why?
| | Polymethacrylic Acids | 2 | 2003 | 61 | 0.090 |
Why?
| | Decorin | 1 | 2009 | 6 | 0.090 |
Why?
| | Biosensing Techniques | 1 | 2011 | 102 | 0.090 |
Why?
| | Lithium | 1 | 2009 | 36 | 0.080 |
Why?
| | Biochemical Phenomena | 1 | 2009 | 10 | 0.080 |
Why?
| | Acrylamides | 1 | 2009 | 43 | 0.080 |
Why?
| | High-Throughput Screening Assays | 1 | 2010 | 124 | 0.080 |
Why?
| | Neoplasms | 1 | 2023 | 2118 | 0.080 |
Why?
| | Cloning, Molecular | 1 | 2010 | 523 | 0.080 |
Why?
| | Keratinocytes | 1 | 2010 | 215 | 0.080 |
Why?
| | Computer Simulation | 2 | 2013 | 884 | 0.080 |
Why?
| | Adrenal Glands | 1 | 2009 | 72 | 0.080 |
Why?
| | Bone Morphogenetic Proteins | 2 | 2007 | 133 | 0.080 |
Why?
| | Fibroblast Growth Factors | 1 | 2010 | 162 | 0.080 |
Why?
| | Cysteine | 1 | 2010 | 173 | 0.080 |
Why?
| | Biotechnology | 1 | 2009 | 46 | 0.080 |
Why?
| | Amino Acid Motifs | 1 | 2009 | 198 | 0.080 |
Why?
| | Mice, Inbred C57BL | 2 | 2010 | 4773 | 0.080 |
Why?
| | Culture Techniques | 1 | 2008 | 80 | 0.080 |
Why?
| | X-Ray Diffraction | 2 | 2005 | 84 | 0.080 |
Why?
| | Serum Albumin | 1 | 2009 | 135 | 0.080 |
Why?
| | Microchemistry | 1 | 2008 | 15 | 0.080 |
Why?
| | Probability | 1 | 2009 | 294 | 0.080 |
Why?
| | Ultrasonics | 1 | 2008 | 48 | 0.080 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2009 | 3256 | 0.080 |
Why?
| | Microbial Sensitivity Tests | 1 | 2009 | 299 | 0.080 |
Why?
| | Fibrin | 1 | 2008 | 65 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 1 | 2011 | 616 | 0.080 |
Why?
| | Integrin alpha5beta1 | 1 | 2008 | 9 | 0.080 |
Why?
| | Matrix Metalloproteinase 13 | 1 | 2008 | 24 | 0.080 |
Why?
| | Surface-Active Agents | 1 | 2008 | 79 | 0.080 |
Why?
| | Integrin alphaVbeta3 | 1 | 2008 | 24 | 0.080 |
Why?
| | Lymphocyte Activation | 1 | 2012 | 1057 | 0.080 |
Why?
| | Lasers | 1 | 2008 | 121 | 0.070 |
Why?
| | Immunosuppressive Agents | 1 | 2012 | 666 | 0.070 |
Why?
| | Surgical Wound Infection | 1 | 2010 | 250 | 0.070 |
Why?
| | Drug Stability | 2 | 2005 | 152 | 0.070 |
Why?
| | Aggrecans | 1 | 2007 | 14 | 0.070 |
Why?
| | Heparan Sulfate Proteoglycans | 1 | 2007 | 22 | 0.070 |
Why?
| | RNA, Small Interfering | 1 | 2009 | 544 | 0.070 |
Why?
| | Mitogens | 1 | 2007 | 58 | 0.070 |
Why?
| | Hepatocyte Growth Factor | 1 | 2007 | 33 | 0.070 |
Why?
| | Calorimetry, Differential Scanning | 3 | 2005 | 34 | 0.070 |
Why?
| | Bioreactors | 1 | 2006 | 45 | 0.070 |
Why?
| | Environment | 1 | 2008 | 337 | 0.070 |
Why?
| | Antigen-Antibody Reactions | 1 | 2006 | 49 | 0.070 |
Why?
| | Water | 1 | 2009 | 412 | 0.070 |
Why?
| | Stem Cell Transplantation | 1 | 2007 | 151 | 0.070 |
Why?
| | Griseofulvin | 1 | 2005 | 2 | 0.070 |
Why?
| | Antineoplastic Agents | 1 | 2017 | 1893 | 0.070 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2207 | 0.070 |
Why?
| | Sensitivity and Specificity | 2 | 2011 | 1730 | 0.070 |
Why?
| | Tetrazolium Salts | 1 | 2005 | 18 | 0.070 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 1001 | 0.060 |
Why?
| | Nanotechnology | 1 | 2007 | 115 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2007 | 277 | 0.060 |
Why?
| | Calcium Phosphates | 1 | 2005 | 25 | 0.060 |
Why?
| | X-Ray Microtomography | 2 | 2019 | 79 | 0.060 |
Why?
| | Antigens, CD | 1 | 2008 | 442 | 0.060 |
Why?
| | Glucagon | 1 | 2005 | 93 | 0.060 |
Why?
| | Ear, External | 1 | 2005 | 23 | 0.060 |
Why?
| | Nasal Septum | 1 | 2005 | 16 | 0.060 |
Why?
| | Thiazoles | 1 | 2005 | 110 | 0.060 |
Why?
| | Enzyme Activation | 1 | 2007 | 793 | 0.060 |
Why?
| | Facial Bones | 1 | 2005 | 30 | 0.060 |
Why?
| | Immunoblotting | 1 | 2005 | 281 | 0.060 |
Why?
| | Nose | 1 | 2005 | 56 | 0.060 |
Why?
| | Cell Count | 1 | 2005 | 305 | 0.060 |
Why?
| | Larynx | 1 | 2005 | 48 | 0.060 |
Why?
| | Stress Fibers | 1 | 2004 | 16 | 0.060 |
Why?
| | Hexuronic Acids | 1 | 2004 | 24 | 0.060 |
Why?
| | Glucuronic Acid | 1 | 2004 | 27 | 0.060 |
Why?
| | Sheep | 1 | 2007 | 765 | 0.060 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2005 | 161 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1447 | 0.060 |
Why?
| | Cytoskeleton | 1 | 2005 | 177 | 0.060 |
Why?
| | Alginates | 1 | 2004 | 44 | 0.060 |
Why?
| | Photography | 1 | 2004 | 89 | 0.060 |
Why?
| | Immunity, Innate | 1 | 2009 | 731 | 0.060 |
Why?
| | Cell Size | 1 | 2004 | 81 | 0.060 |
Why?
| | Surgical Flaps | 1 | 2005 | 121 | 0.060 |
Why?
| | Catalysis | 2 | 2017 | 299 | 0.060 |
Why?
| | Gene Transfer Techniques | 1 | 2004 | 148 | 0.050 |
Why?
| | Magnetic Phenomena | 1 | 2023 | 9 | 0.050 |
Why?
| | Trachea | 1 | 2005 | 233 | 0.050 |
Why?
| | Diabetes Mellitus | 1 | 2011 | 908 | 0.050 |
Why?
| | Oxidation-Reduction | 3 | 2011 | 924 | 0.050 |
Why?
| | Cystatin C | 1 | 2022 | 61 | 0.050 |
Why?
| | Cellular Senescence | 1 | 2023 | 153 | 0.050 |
Why?
| | Infant, Newborn | 2 | 2010 | 5060 | 0.050 |
Why?
| | Injections | 1 | 2002 | 161 | 0.050 |
Why?
| | Biomarkers, Pharmacological | 1 | 2022 | 26 | 0.050 |
Why?
| | Somatomedins | 1 | 2002 | 29 | 0.050 |
Why?
| | Subcutaneous Tissue | 1 | 2002 | 17 | 0.050 |
Why?
| | Technology, Pharmaceutical | 1 | 2002 | 19 | 0.050 |
Why?
| | Paneth Cells | 1 | 2022 | 17 | 0.050 |
Why?
| | Genetic Therapy | 1 | 2003 | 260 | 0.050 |
Why?
| | Femur | 2 | 2019 | 194 | 0.050 |
Why?
| | Tissue Culture Techniques | 1 | 2022 | 67 | 0.050 |
Why?
| | Cicatrix | 1 | 2022 | 50 | 0.050 |
Why?
| | Receptors, Notch | 1 | 2022 | 85 | 0.050 |
Why?
| | Chlorobenzenes | 1 | 2001 | 8 | 0.050 |
Why?
| | Temporomandibular Joint Disorders | 1 | 2001 | 9 | 0.050 |
Why?
| | Succinimides | 1 | 2001 | 15 | 0.050 |
Why?
| | Chromosomes | 1 | 2021 | 85 | 0.050 |
Why?
| | Nucleic Acid Conformation | 1 | 2004 | 672 | 0.050 |
Why?
| | Polyglycolic Acid | 1 | 2001 | 43 | 0.050 |
Why?
| | Lung | 1 | 2013 | 3673 | 0.050 |
Why?
| | Adrenergic beta-Agonists | 1 | 2021 | 129 | 0.040 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2000 | 139 | 0.040 |
Why?
| | Mathematical Computing | 1 | 2000 | 12 | 0.040 |
Why?
| | Gonadal Steroid Hormones | 1 | 2021 | 124 | 0.040 |
Why?
| | Mitochondria | 1 | 2005 | 750 | 0.040 |
Why?
| | Fumarates | 1 | 2019 | 10 | 0.040 |
Why?
| | Ursidae | 1 | 2019 | 7 | 0.040 |
Why?
| | Polypropylenes | 1 | 2019 | 16 | 0.040 |
Why?
| | Antibodies, Monoclonal | 1 | 2006 | 1265 | 0.040 |
Why?
| | Lipids | 1 | 2003 | 588 | 0.040 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2000 | 130 | 0.040 |
Why?
| | Muscles | 1 | 2001 | 326 | 0.040 |
Why?
| | Zebrafish | 1 | 2023 | 412 | 0.040 |
Why?
| | Models, Genetic | 1 | 2022 | 570 | 0.040 |
Why?
| | Spectrophotometry, Infrared | 1 | 1999 | 44 | 0.040 |
Why?
| | Intracellular Space | 1 | 2019 | 68 | 0.040 |
Why?
| | Inflammation | 1 | 2009 | 2500 | 0.040 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 2018 | 37 | 0.040 |
Why?
| | Drug Liberation | 1 | 2018 | 25 | 0.040 |
Why?
| | Prosthesis Implantation | 1 | 1999 | 139 | 0.040 |
Why?
| | Protein Transport | 1 | 2019 | 400 | 0.040 |
Why?
| | RNA, Messenger | 1 | 2004 | 2574 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2018 | 850 | 0.040 |
Why?
| | Proteomics | 1 | 2022 | 859 | 0.030 |
Why?
| | Quality Control | 1 | 1996 | 148 | 0.030 |
Why?
| | Genotype | 1 | 2021 | 1787 | 0.030 |
Why?
| | Ketanserin | 1 | 1996 | 12 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2019 | 553 | 0.030 |
Why?
| | Sclerosis | 1 | 2014 | 11 | 0.030 |
Why?
| | Collagen Type III | 1 | 2014 | 18 | 0.030 |
Why?
| | Receptors, Wnt | 1 | 2013 | 2 | 0.030 |
Why?
| | Coatomer Protein | 1 | 2013 | 3 | 0.030 |
Why?
| | ras GTPase-Activating Proteins | 1 | 2013 | 13 | 0.030 |
Why?
| | Wnt-5a Protein | 1 | 2013 | 19 | 0.030 |
Why?
| | Exocytosis | 1 | 2014 | 89 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2016 | 748 | 0.030 |
Why?
| | Myosins | 1 | 2013 | 126 | 0.030 |
Why?
| | Cell Polarity | 1 | 2013 | 131 | 0.030 |
Why?
| | Multiprotein Complexes | 1 | 2013 | 145 | 0.030 |
Why?
| | Myocardial Infarction | 1 | 2019 | 931 | 0.030 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 1996 | 399 | 0.030 |
Why?
| | Algorithms | 1 | 1999 | 1500 | 0.020 |
Why?
| | Pilot Projects | 1 | 2016 | 1384 | 0.020 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 177 | 0.020 |
Why?
| | Skin | 2 | 2010 | 662 | 0.020 |
Why?
| | Microtubules | 1 | 2013 | 238 | 0.020 |
Why?
| | Ear Cartilage | 1 | 2010 | 3 | 0.020 |
Why?
| | Biomedical Research | 1 | 2017 | 589 | 0.020 |
Why?
| | Integrin beta4 | 1 | 2010 | 1 | 0.020 |
Why?
| | Keratin-14 | 1 | 2010 | 12 | 0.020 |
Why?
| | Enzymes, Immobilized | 1 | 2011 | 36 | 0.020 |
Why?
| | Dermis | 1 | 2010 | 30 | 0.020 |
Why?
| | Pseudomonas aeruginosa | 1 | 2012 | 301 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2010 | 310 | 0.020 |
Why?
| | Physical Phenomena | 1 | 2009 | 12 | 0.020 |
Why?
| | Amino Acids | 1 | 2013 | 454 | 0.020 |
Why?
| | Dimerization | 2 | 1999 | 177 | 0.020 |
Why?
| | Cell Lineage | 1 | 2010 | 310 | 0.020 |
Why?
| | Escherichia coli | 1 | 2012 | 730 | 0.020 |
Why?
| | Buffers | 1 | 2007 | 54 | 0.020 |
Why?
| | Rats, Inbred Lew | 1 | 2007 | 93 | 0.020 |
Why?
| | Skull Fractures | 1 | 2007 | 28 | 0.020 |
Why?
| | Nanocomposites | 1 | 2007 | 17 | 0.020 |
Why?
| | Protons | 1 | 2007 | 80 | 0.020 |
Why?
| | Chromatography, Supercritical Fluid | 1 | 2005 | 3 | 0.020 |
Why?
| | Chemical Precipitation | 1 | 2005 | 38 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 9162 | 0.020 |
Why?
| | Powders | 1 | 2005 | 38 | 0.020 |
Why?
| | Excipients | 1 | 2005 | 49 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2007 | 377 | 0.020 |
Why?
| | Solutions | 1 | 2004 | 150 | 0.010 |
Why?
| | DNA Replication | 1 | 2004 | 203 | 0.010 |
Why?
| | Models, Statistical | 1 | 2006 | 606 | 0.010 |
Why?
| | Patella | 1 | 2000 | 25 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2004 | 1122 | 0.010 |
Why?
| | Injections, Subcutaneous | 1 | 1999 | 137 | 0.010 |
Why?
| | Adhesiveness | 1 | 1996 | 19 | 0.010 |
Why?
| | Freezing | 1 | 1996 | 85 | 0.010 |
Why?
| | Mucins | 1 | 1996 | 61 | 0.010 |
Why?
|
|
Anseth's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|